T46.7X5A Adverse effect of peripheral vasodilators, initial encounter |
T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter |
T46.7X5S Adverse effect of peripheral vasodilators, sequela |
T46.7X6A Underdosing of peripheral vasodilators, initial encounter |
T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter |
T46.7X6S Underdosing of peripheral vasodilators, sequela |
T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter |
T46.8X1D Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter |
T46.8X1S Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela |
T46.8X2A Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter |
T46.8X2D Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter |
T46.8X2S Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela |
T46.8X3A Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter |
T46.8X3D Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter |
T46.8X3S Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela |
T46.8X4A Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter |
T46.8X4D Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter |
T46.8X4S Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela |
T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter |
T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter |
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela |
T46.8X6A Underdosing of antivaricose drugs, including sclerosing agents, initial encounter |
T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter |
T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela |
T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
T46.901D Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter |
T46.901S Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela |
T46.902A Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
T46.902D Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter |
T46.902S Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela |
T46.903A Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter |
T46.903D Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter |
T46.903S Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela |
T46.904A Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter |
T46.904D Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter |
T46.904S Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela |
T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter |
T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela |
T46.906A Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter |
T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela |
T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
T46.991D Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter |
T46.991S Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela |
T46.992A Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
T46.992D Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter |
T46.992S Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela |
T46.993A Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter |
T46.993D Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter |
T46.993S Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela |
T46.994A Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter |
T46.994D Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter |
T46.994S Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela |
T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter |
T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter |
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela |
T46.996A Underdosing of other agents primarily affecting the cardiovascular system, initial encounter |
T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter |
T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela |
T47.0X1A Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter |
T47.0X1D Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter |
T47.0X1S Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela |
T47.0X2A Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter |
T47.0X2D Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter |
T47.0X2S Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela |
T47.0X3A Poisoning by histamine H2-receptor blockers, assault, initial encounter |
T47.0X3D Poisoning by histamine H2-receptor blockers, assault, subsequent encounter |
T47.0X3S Poisoning by histamine H2-receptor blockers, assault, sequela |
T47.0X4A Poisoning by histamine H2-receptor blockers, undetermined, initial encounter |
T47.0X4D Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter |
T47.0X4S Poisoning by histamine H2-receptor blockers, undetermined, sequela |
T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter |
T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter |
T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela |
T47.0X6A Underdosing of histamine H2-receptor blockers, initial encounter |
T47.0X6D Underdosing of histamine H2-receptor blockers, subsequent encounter |
T47.0X6S Underdosing of histamine H2-receptor blockers, sequela |
T47.1X1A Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter |
T47.1X1D Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter |
T47.1X1S Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela |
T47.1X2A Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter |
T47.1X2D Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter |
T47.1X2S Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela |
T47.1X3A Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter |
T47.1X3D Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter |
T47.1X3S Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela |
T47.1X4A Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter |
T47.1X4D Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter |
T47.1X4S Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela |
T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter |
T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter |
T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela |
T47.1X6A Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter |
T47.1X6D Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter |
T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela |
T47.2X1A Poisoning by stimulant laxatives, accidental (unintentional), initial encounter |
T47.2X1D Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter |
T47.2X1S Poisoning by stimulant laxatives, accidental (unintentional), sequela |
T47.2X2A Poisoning by stimulant laxatives, intentional self-harm, initial encounter |